IIT Guwahati and Miraclus Orthotech join forces to drive breakthroughs in orthopaedic technology

January 29, 2025 | Wednesday | News

The partnership will initiate industry-academia exchange programmes

Indian Institute of Technology Guwahati (IIT-G) has signed a Memorandum of Understanding (MoU) with Miraclus Orthotech, a leading orthopedic implant manufacturer, to collaborate on innovative research, development, and testing of advanced orthopedic implants and instruments. 

This partnership marks a significant milestone in advancing biomedical engineering by combining IIT Guwahati's expertise in cutting-edge research with Miraclus Orthotech's industry leadership. Together, they aim to address critical challenges in the medical device sector and deliver high-quality, efficient solutions to improve patient care.

The partnership will focus on four key areas:

  • Research and Development: Joint efforts to design next-generation orthopedic implants and instruments.
  • Product Testing and Validation: Leveraging IIT Guwahati's state-of-the-art facilities to ensure products meet global quality standards.
  • Skill Development: Conducting workshops, training programs, and knowledge-sharing sessions to provide students and researchers with practical exposure to medical device technology.
  • Intellectual Property Creation: Co-developing patents and publishing research outcomes to advance the field.

As the next step, IIT Guwahati jointly with Miraclus plans to establish a facility equipped with advanced prototyping and testing tools for orthopedic implants and instruments. This facility will serve as a hub for interdisciplinary research, bringing together experts from biomedical engineering, materials science, and clinical practice.

Additionally, the partnership will initiate industry-academia exchange programmes, allowing researchers and students to work closely with industry professionals to bridge the gap between theoretical research and practical implementation. A roadmap for regulatory approvals and commercialisation will also be developed to accelerate the transition of innovative medical devices from the lab to the market.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy